Visfatin was originally described as an adipokine with insulin mimetic effects. Recently, it was found that visfatin is identical with the Nampt (nicotinamide phosphoribosyltransferase) gene that codes for an intra- and extracellular NAD biosynthetic enzyme and is predominantly expressed outside the adipose tissue. In the current study, we found strong protein and mRNA expression of visfatin in rat heart, liver, kidney, and muscle, while the expression of visfatin in visceral fat was significantly lower and undetectable in subcutaneous fat. The insulin-mimetic effects of visfatin (extracellular form of Nampt or eNampt) are controversial and even less is known about autocrine effects of visfatin (intracellular form of Nampt or iNampt). Since liver plays a major role in glucose metabolism, we studied visfatin effects on insulin-stimulated cellular glucose uptake in Fao rat hepatocytes using RNA interference (RNAi). RNAi-mediated downregulation of visfatin expression in Fao cells was associated with significantly reduced NAD biosynthesis (0.3±0.01 vs. 0.5±0.01 mmol/h/g, P<0.05) and with significantly decreased incremental glucose uptake after stimulation with insulin when compared to controls with normal expression of visfatin (0.6±0.2 vs. 2.2±0.5 nnmol/g/2 h, P=0.02). These results provide evidence that visfatin exhibits important autocrine effects on sensitivity of liver cells to insulin action possibly through its effects on NAD biosynthesis.

Inst Physiol Acad Sci Czech Rep Prague

Lit.: 11

000      

00000naa 2200000 a 4500

001      

bmc11000534

003      

CZ-PrNML

005      

20140724105952.0

008      

110202s2010 xr e eng||

009      

AR

024    7_

$a 10.33549/physiolres.931845 $2 doi

040    __

$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Škop, Vojtěch $7 xx0121451

245    10

$a Autocrine effects of visfatin on hepatocyte sensitivity to insulin action / $c V. Škop, K. Kontrová, V. Zídek, M. Pravenec, L. Kazdová, K. Mikulík, J. Sajdok, J. Zídková

314    __

$a Inst. Physiol., Acad. Sci. Czech Rep., Prague

504    __

$a Lit.: 11

520    9_

$a Visfatin was originally described as an adipokine with insulin mimetic effects. Recently, it was found that visfatin is identical with the Nampt (nicotinamide phosphoribosyltransferase) gene that codes for an intra- and extracellular NAD biosynthetic enzyme and is predominantly expressed outside the adipose tissue. In the current study, we found strong protein and mRNA expression of visfatin in rat heart, liver, kidney, and muscle, while the expression of visfatin in visceral fat was significantly lower and undetectable in subcutaneous fat. The insulin-mimetic effects of visfatin (extracellular form of Nampt or eNampt) are controversial and even less is known about autocrine effects of visfatin (intracellular form of Nampt or iNampt). Since liver plays a major role in glucose metabolism, we studied visfatin effects on insulin-stimulated cellular glucose uptake in Fao rat hepatocytes using RNA interference (RNAi). RNAi-mediated downregulation of visfatin expression in Fao cells was associated with significantly reduced NAD biosynthesis (0.3±0.01 vs. 0.5±0.01 mmol/h/g, P<0.05) and with significantly decreased incremental glucose uptake after stimulation with insulin when compared to controls with normal expression of visfatin (0.6±0.2 vs. 2.2±0.5 nnmol/g/2 h, P=0.02). These results provide evidence that visfatin exhibits important autocrine effects on sensitivity of liver cells to insulin action possibly through its effects on NAD biosynthesis.

650    _2

$a financování organizované $7 D005381

650    _2

$a zvířata $7 D000818

650    _2

$a autokrinní signalizace $7 D019898

650    _2

$a biologický transport $7 D001692

650    _2

$a buněčné linie $7 D002460

650    _2

$a cytokiny $x genetika $x metabolismus $7 D016207

650    _2

$a regulace genové exprese enzymů $7 D015971

650    _2

$a glukosa $x metabolismus $7 D005947

650    _2

$a hepatocyty $x enzymologie $7 D022781

650    _2

$a inzulin $x metabolismus $7 D007328

650    _2

$a inzulinová rezistence $7 D007333

650    _2

$a NAD $x metabolismus $7 D009243

650    _2

$a nikotinamidfosforibosyltransferasa $x genetika $x metabolismus $7 D054409

650    _2

$a RNA interference $7 D034622

650    _2

$a messenger RNA $x metabolismus $7 D012333

650    _2

$a krysa rodu Rattus $7 D051381

650    _2

$a potkani inbrední WKY $7 D011921

700    1_

$a Kontrová, Kateřina. $7 _BN005817

700    1_

$a Zídek, Václav, $d 1951- $7 xx0088482

700    1_

$a Pravenec, Michal, $d 1953- $7 nlk20030127611

700    1_

$a Kazdová, Ludmila, $d 1938- $7 xx0053119

700    1_

$a Mikulík, Karel. $7 _BN001380

700    1_

$a Sajdok, Jiří $7 xx0107859

700    1_

$a Zídková, Jarmila $7 xx0074470

773    0_

$w MED00003824 $t Physiological research $g Roč. 59, č. 4 (2010), s. 615-618 $x 0862-8408

856    41

$u http://www.biomed.cas.cz/physiolres/pdf/59/59_615.pdf $y plný text volně přístupný

910    __

$a ABA008 $b A 4120 $c 266 $y 7 $z 0

990    __

$a 20110131162710 $b ABA008

991    __

$a 20140724110302 $b ABA008

999    __

$a ok $b bmc $g 827565 $s 692403

BAS    __

$a 3

BMC    __

$a 2010 $b 59 $c 4 $m Physiological research $x MED00003824 $d 615-618

GRA    __

$a NR9387 $p MZ0

GRA    __

$a NR9359 $p MZ0

LZP    __

$a 2011-05/dkme